Brazilian hemorrhagic fever

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319239A96.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Brazilian hemorrhagic fever (BHF) is a very rare and serious viral infection caused by the Sabiá virus, which belongs to a group of viruses called arenaviruses. This disease was first identified in Brazil in 1990 and has only been reported in a handful of cases. The Sabiá virus is believed to be carried by rodents, and people can become infected through contact with rodent droppings, urine, or saliva, or possibly through inhaling tiny particles contaminated with the virus. Person-to-person spread has also been documented, particularly in healthcare settings. The disease typically begins with flu-like symptoms such as fever, muscle aches, and feeling generally unwell. As it progresses, patients may develop more severe symptoms including bleeding from the gums, skin, or internal organs, which is why it is called a hemorrhagic fever. Other symptoms can include nausea, vomiting, abdominal pain, sore throat, and in severe cases, shock and organ failure. The illness can be life-threatening. There is no specific approved treatment or vaccine for Brazilian hemorrhagic fever. Supportive care in a hospital setting is the main approach, which includes managing fluids, blood pressure, and bleeding. The antiviral drug ribavirin has been used in some cases and may offer some benefit, especially when given early in the course of illness. Because of its potential for person-to-person spread, strict infection control measures are essential when caring for patients with this disease.

Also known as:

Key symptoms:

High feverSevere headacheMuscle aches and body painFatigue and weaknessNausea and vomitingAbdominal painSore throatBleeding from the gumsSkin bruising or bleeding under the skinDizziness or lightheadednessLow blood pressureFacial swellingInternal bleedingShock in severe cases

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Brazilian hemorrhagic fever.

View clinical trials →

No actively recruiting trials found for Brazilian hemorrhagic fever at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Brazilian hemorrhagic fever community →

No specialists are currently listed for Brazilian hemorrhagic fever.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Brazilian hemorrhagic fever.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Brazilian hemorrhagic feverForum →

No community posts yet. Be the first to share your experience with Brazilian hemorrhagic fever.

Start the conversation →

Latest news about Brazilian hemorrhagic fever

No recent news articles for Brazilian hemorrhagic fever.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How was the diagnosis of Brazilian hemorrhagic fever confirmed in my case?,What treatments are available, and is ribavirin being considered?,What precautions should my family and close contacts take to avoid infection?,How long is the expected recovery period?,Are there any long-term health effects I should watch for?,Should my close contacts be tested or monitored for symptoms?,What should I do if my symptoms return or worsen after leaving the hospital?

Common questions about Brazilian hemorrhagic fever

What is Brazilian hemorrhagic fever?

Brazilian hemorrhagic fever (BHF) is a very rare and serious viral infection caused by the Sabiá virus, which belongs to a group of viruses called arenaviruses. This disease was first identified in Brazil in 1990 and has only been reported in a handful of cases. The Sabiá virus is believed to be carried by rodents, and people can become infected through contact with rodent droppings, urine, or saliva, or possibly through inhaling tiny particles contaminated with the virus. Person-to-person spread has also been documented, particularly in healthcare settings. The disease typically begins with

How is Brazilian hemorrhagic fever inherited?

Brazilian hemorrhagic fever follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.